Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy

Open Access

Peer-reviewed

Research Article

Marjolein Sluijter,

Affiliation Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands
⨯
Tetje C. van der Sluis,

Affiliation Department of Immunohematology and Bloodtransfusion, Leiden University Medical Center, Leiden, the Netherlands
⨯
Pieter A. van der Velden,

Affiliation Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands
⨯
Mieke Versluis,

Affiliation Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands
⨯
Brian L. West,

Affiliation Plexxikon Inc., Berkeley, California, United States of America
⨯
Sjoerd H. van der Burg,

Affiliation Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands
⨯
Thorbald van Hall

* E-mail: T.van_Hall@lumc.nl

Affiliation Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands
⨯

Reader Comments (0)

Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Macrophages
Is the Subject Area "Macrophages" applicable to this article?

Thanks for your feedback.
Cancer immunotherapy
Is the Subject Area "Cancer immunotherapy" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Melanoma
Is the Subject Area "Melanoma" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.